New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

CVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges.

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 ...

Leon Wang, EVP international and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese ...

New clinical trial data show there is no benefit to waiting when it comes to heart-valve replacement surgery. Other news includes: Ozempic and Wegovy now available, after long shortage; AirPods Pro ...

Axonis Therapeutics, a biotechnology company focused on the development of novel neuromedicines, announced today the successful completion of an oversubscribed $115 million Series A financing.

Vutrisiran MarketThe global vutrisiran market, valued at USD 600 million in 2022, is expected to experience substantial growth, reaching an estimated USD 2,087 million by 2033, with a compound annual ...

New Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central ...

A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...

Before joining BeiGene, Yin spent 15 years with AstraZeneca, having served in various posts at the British drugmaker, including as head of its oncology business in China. Yin has been detained by ...

Credit: Olena Yakobchuk/Shutterstock. The European Union’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AstraZeneca and Ionis Pharmaceuticals’ Wainzua ...